Trilogy Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.92M | Sell |
|
|||||
|
2025
Q2 | $4.01M | Sell |
|
|||||
|
2025
Q1 | $4.63M | Buy |
|
|||||
|
2024
Q4 | $2.81M | Buy |
|
|||||
|
2024
Q3 | $897K | Sell |
|
|||||
|
2024
Q2 | $805K | Sell |
|
|||||
|
2024
Q1 | $868K | Sell |
|
|||||
|
2023
Q4 | $3.05M | Sell |
|
|||||
|
2023
Q3 | $2.96M | Buy |
|
|||||
|
2023
Q2 | $2.84M | Buy |
|
|||||
|
2023
Q1 | $3.03M | Buy |
|
|||||
|
2022
Q4 | $2.57M | Buy |
|
|||||
|
2022
Q3 | $1.83M | Buy |
|
|||||
|
2022
Q2 | $1.84M | Sell |
|
|||||
|
2022
Q1 | $2.02M | Buy |
|
|||||
|
2021
Q4 | $1.43M | Buy |
|
|||||
|
2021
Q3 | $1.09M | Buy |
|
|||||
|
2021
Q2 | $1.19M | Buy |
|
|||||
|
2021
Q1 | $846K | Buy |
|
|||||
|
2020
Q4 | $703K | Buy |
|
|||||
|
2020
Q3 | $567K | Sell |
|
|||||
|
2020
Q2 | $680K | Sell |
|
|||||
|
2020
Q1 | $593K | Sell |
|
|||||
|
2019
Q4 | $780K | Buy |
|
|||||
|
2019
Q3 | $612K | Buy |
|
|||||
|
2019
Q2 | $518K | Buy |
|
|||||
|
2019
Q1 | $526K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $21K | Buy |
|
|||||
|
2018
Q2 | $21K | Sell |
|
|||||
|
2018
Q1 | $21K | Sell |
|
|||||
|
2017
Q4 | $789K | Buy |
|